XML 23 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Total Stockholders' Equity
Common Stock
Additional
Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Non-Controlling Interests
Beginning balance (in shares) at Dec. 31, 2020     567,117,666        
Beginning balance at Dec. 31, 2020 $ 8,556,073 $ 8,504,825 $ 5,671 $ 9,707,258 $ (661,162) $ (546,942) $ 51,248
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Capital distributions (2,107)           (2,107)
Net income 262,776 261,425     261,425   1,351
Dividends and dividend equivalents declared (395,132) (395,132)     (395,132)    
Issuance of common stock — settlement of RSUs, net of tax (in shares)     675,870        
Issuance of common stock — settlement of RSUs, net of tax (9,411) (9,411) $ 7 (9,418)      
Issuance of common stock — settlement of 2022 Convertible Notes (in shares)     8,943,374        
Issuance of common stock — settlement of 2022 Convertible Notes $ 203,509 203,509 $ 89 203,420      
Issuance of common stock, net (in shares) 33,927,772   23,383,528        
Issuance of common stock, net $ 933,790 933,790 $ 234 933,556      
Share-based compensation expense 27,170 25,066   25,066     2,104
Total other comprehensive income (loss) 262,136 260,553       260,553 1,583
Redemption of OP Units for common stock (in shares)     925,000        
Redemption of OP Units for common stock 0 13,117 $ 9 13,657   (549) (13,117)
Ending balance (in shares) at Dec. 31, 2021     601,045,438        
Ending balance at Dec. 31, 2021 9,838,804 9,797,742 $ 6,010 10,873,539 (794,869) (286,938) 41,062
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Capital distributions (2,397)           (2,397)
Net income 384,799 383,329     383,329   1,470
Dividends and dividend equivalents declared (539,680) (539,680)     (539,680)    
Issuance of common stock — settlement of RSUs, net of tax (in shares)     660,756        
Issuance of common stock — settlement of RSUs, net of tax (12,869) (12,869) $ 7 (12,876)      
Issuance of common stock — settlement of 2022 Convertible Notes (in shares)     6,216,261        
Issuance of common stock — settlement of 2022 Convertible Notes $ 141,219 141,219 $ 62 141,157      
Issuance of common stock, net (in shares) 10,365,944   2,438,927        
Issuance of common stock, net $ 98,367 98,367 $ 25 98,342      
Share-based compensation expense 28,962 24,950   24,950     4,012
Total other comprehensive income (loss) 386,426 384,850       384,850 1,576
Redemption of OP Units for common stock (in shares)     1,050,000        
Redemption of OP Units for common stock $ 0 13,434 $ 10 13,351   73 (13,434)
Ending balance (in shares) at Dec. 31, 2022 611,411,382   611,411,382        
Ending balance at Dec. 31, 2022 $ 10,323,631 10,291,342 $ 6,114 11,138,463 (951,220) 97,985 32,289
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Capital distributions (2,374)           (2,374)
Net income 521,028 519,470     519,470   1,558
Dividends and dividend equivalents declared (638,836) (638,836)     (638,836)    
Issuance of common stock — settlement of RSUs, net of tax (in shares)     546,857        
Issuance of common stock — settlement of RSUs, net of tax $ (8,149) (8,149) $ 6 (8,155)      
Issuance of common stock, net (in shares) 546,857            
Share-based compensation expense $ 29,503 26,428   26,428     3,075
Total other comprehensive income (loss) $ (34,368) (34,284)       (34,284) (84)
Ending balance (in shares) at Dec. 31, 2023 611,958,239   611,958,239        
Ending balance at Dec. 31, 2023 $ 10,190,435 $ 10,155,971 $ 6,120 $ 11,156,736 $ (1,070,586) $ 63,701 $ 34,464